We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
- Authors
Abaid, Lisa N; Micha, John P; Rettenmaier, Mark A; Brown, John V; Mendivil, Alberto A; Lopez, Katrina L; Goldstein, Bram H
- Abstract
Traditional dose-dense chemotherapy regimens for advanced stage ovarian cancer incorporate weekly paclitaxel on a 21-day cycle and are associated with favorable efficacy but high rates of neutropenia, thrombocytopenia, and anemia. The purpose of this phase II study was to assess the response rate and toxicity of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage ovarian, fallopian tube, and primary peritoneal carcinoma.
- Publication
Cancer chemotherapy and pharmacology, 2013, Vol 72, Issue 1, p101
- ISSN
1432-0843
- Publication type
Journal Article
- DOI
10.1007/s00280-013-2173-2